Last 12 months
Inside the activity.
3 purchase rows · 0 sale rows
Disclosed non-derivative P/S rows, by transaction month. Includes amendments and private transactions.Monthly counts
| Month | Purchases | Sales |
|---|---|---|
| Nov 2025 | 0 | 0 |
| Dec 2025 | 0 | 0 |
| Jan 2026 | 0 | 0 |
| Feb 2026 | 0 | 0 |
| Mar 2026 | 0 | 0 |
| Apr 2026 | 0 | 0 |
| May 2026 | 1 | 0 |
| Jun 2026 | 0 | 0 |
| Jul 2026 | 0 | 0 |
| Aug 2026 | 2 | 0 |
| Sep 2026 | 0 | 0 |
| Oct 2026 | 0 | 0 |
Latest available
Insider transactions
Purchases/sales include open-market and private transactions. Plan disclosure applies to the filing; individual rows may differ. “Not disclosed” is not “unplanned.”
The cutoff filters transaction history only. Company summaries and owner relationships show the latest available disclosures. Parser corrections can improve historical records.
| Transaction date | Owner / reported role | Activity / security | Shares / units | Reported price | Reported value | Details |
|---|---|---|---|---|---|---|
| November 18, 2021 Filed Jan 5, 2022 21:06 UTC |
CRANDELL KEITHDirector · 10% owner
|
OtherCommon Stock | 113,003 | $0.00 | $0.00 |
DisclosureSEC source: 0001562180-22-000232 · primarydocument.xml · nonDerivative · entry 5 CRANDELL KEITH · CIK 0001219039 · Director · 10% owner 10b5-1 filing: Not disclosed Ownership: Indirect · See Footnote Disclosed balance after: 0 F1 · kind: Distribution of Common Stock held by a limited partnership to its partners for no consideration. F3 · ownership.nature: These shares are directly held by ARCH Venture Fund VIII Overage, L.P. ("ARCH Overage"). ARCH Venture Partners VIII, LLC ("ARCH VIII LLC") the sole general partner of ARCH Overage, may be deemed to beneficially own the shares held by ARCH Overage. The Reporting Person is a managing director of the ARCH VIII LLC and shares voting and investment control with respect to these shares. The Reporting Person may be deemed to beneficially own the shares held by ARCH Overage. The Reporting Person disclaims beneficial ownership of the securities reported herein, except to the extent of his pecuniary interest therein, if any. Read SEC document |
| November 18, 2021 Filed Jan 5, 2022 21:06 UTC |
CRANDELL KEITHDirector · 10% owner
|
OtherCommon Stock | 177,247 | $0.00 | $0.00 |
DisclosureSEC source: 0001562180-22-000232 · primarydocument.xml · nonDerivative · entry 4 CRANDELL KEITH · CIK 0001219039 · Director · 10% owner 10b5-1 filing: Not disclosed Ownership: Indirect · See footnote Disclosed balance after: 0 F1 · kind: Distribution of Common Stock held by a limited partnership to its partners for no consideration. F2 · ownership.nature: These shares are directly held by ARCH Venture Fund VI, L.P. ("ARCH VI"). ARCH Venture Partners VI, L.P. ("GPLP"), the sole general partner of ARCH VI, may be deemed to beneficially own the shares held by ARCH VI. ARCH Venture Partners VI, LLC ("GPLLC"), as the sole general partner of GPLP, may be deemed to beneficially own the shares held by ARCH VI. The Reporting Person is a managing director of the GPLLC and shares voting and investment control with respect to these shares. The Reporting Person may be deemed to beneficially own the shares held by ARCH VI. The Reporting Person disclaims beneficial ownership of the securities reported herein, except to the extent of his pecuniary interest therein, if any. Read SEC document |
| November 16, 2021 Filed Jan 5, 2022 21:06 UTC |
CRANDELL KEITHDirector · 10% owner
|
OtherCommon Stock | 9,952 | $0.00 | $0.00 |
DisclosureSEC source: 0001562180-22-000232 · primarydocument.xml · nonDerivative · entry 3 CRANDELL KEITH · CIK 0001219039 · Director · 10% owner 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 105,964 F1 · kind: Distribution of Common Stock held by a limited partnership to its partners for no consideration. F4 · kind: Change from indirect to direct ownership of shares previously reported as beneficially owned by the Reporting Person. Read SEC document |
| November 16, 2021 Filed Jan 5, 2022 21:06 UTC |
CRANDELL KEITHDirector · 10% owner
|
OtherCommon Stock | 120,689 | $0.00 | $0.00 |
DisclosureSEC source: 0001562180-22-000232 · primarydocument.xml · nonDerivative · entry 2 CRANDELL KEITH · CIK 0001219039 · Director · 10% owner 10b5-1 filing: Not disclosed Ownership: Indirect · See Footnote Disclosed balance after: 113,003 F1 · kind: Distribution of Common Stock held by a limited partnership to its partners for no consideration. F3 · ownership.nature: These shares are directly held by ARCH Venture Fund VIII Overage, L.P. ("ARCH Overage"). ARCH Venture Partners VIII, LLC ("ARCH VIII LLC") the sole general partner of ARCH Overage, may be deemed to beneficially own the shares held by ARCH Overage. The Reporting Person is a managing director of the ARCH VIII LLC and shares voting and investment control with respect to these shares. The Reporting Person may be deemed to beneficially own the shares held by ARCH Overage. The Reporting Person disclaims beneficial ownership of the securities reported herein, except to the extent of his pecuniary interest therein, if any. Read SEC document |
| November 16, 2021 Filed Jan 5, 2022 21:06 UTC |
CRANDELL KEITHDirector · 10% owner
|
OtherCommon Stock | 189,311 | $0.00 | $0.00 |
DisclosureSEC source: 0001562180-22-000232 · primarydocument.xml · nonDerivative · entry 1 CRANDELL KEITH · CIK 0001219039 · Director · 10% owner 10b5-1 filing: Not disclosed Ownership: Indirect · See footnote Disclosed balance after: 177,247 F1 · kind: Distribution of Common Stock held by a limited partnership to its partners for no consideration. F2 · ownership.nature: These shares are directly held by ARCH Venture Fund VI, L.P. ("ARCH VI"). ARCH Venture Partners VI, L.P. ("GPLP"), the sole general partner of ARCH VI, may be deemed to beneficially own the shares held by ARCH VI. ARCH Venture Partners VI, LLC ("GPLLC"), as the sole general partner of GPLP, may be deemed to beneficially own the shares held by ARCH VI. The Reporting Person is a managing director of the GPLLC and shares voting and investment control with respect to these shares. The Reporting Person may be deemed to beneficially own the shares held by ARCH VI. The Reporting Person disclaims beneficial ownership of the securities reported herein, except to the extent of his pecuniary interest therein, if any. Read SEC document |
| November 10, 2021 Filed Nov 10, 2021 16:06 UTC |
HRUSOVSKY E KEVINDirector · Chairman and CEO
|
SaleCommon Stock | 400 | $55.97 | $22,387.00 |
DisclosureSEC source: 0001562180-21-006965 · primarydocument.xml · nonDerivative · entry 3 HRUSOVSKY E KEVIN · CIK 0001252546 · Director · Chairman and CEO 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 897,811 F1 · shares: The sale of shares was effected pursuant to a 10b5-1 trading plan adopted on December 14, 2020. F5 · price: This transaction was executed in multiple trades at prices ranging from $55.93 to $56.015. The price reported reflects the weighted average sale price. The reporting person undertakes to provide upon request to the SEC staff, the issuer or any security holder of the issuer full information regarding the number of shares and prices at which the transaction was effected. F3 · balance_after: Includes 65,504 restricted stock units and 39,815 shares of common stock that are subject to performance based vesting. Read SEC document |
| November 10, 2021 Filed Nov 10, 2021 16:06 UTC |
HRUSOVSKY E KEVINDirector · Chairman and CEO
|
SaleCommon Stock | 3,700 | $55.37 | $204,861.97 |
DisclosureSEC source: 0001562180-21-006965 · primarydocument.xml · nonDerivative · entry 2 HRUSOVSKY E KEVIN · CIK 0001252546 · Director · Chairman and CEO 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 898,211 F1 · shares: The sale of shares was effected pursuant to a 10b5-1 trading plan adopted on December 14, 2020. F4 · price: This transaction was executed in multiple trades at prices ranging from $54.76 to $55.755. The price reported reflects the weighted average sale price. The reporting person undertakes to provide upon request to the SEC staff, the issuer or any security holder of the issuer full information regarding the number of shares and prices at which the transaction was effected. F3 · balance_after: Includes 65,504 restricted stock units and 39,815 shares of common stock that are subject to performance based vesting. Read SEC document |
| November 10, 2021 Filed Nov 10, 2021 16:06 UTC |
HRUSOVSKY E KEVINDirector · Chairman and CEO
|
SaleCommon Stock | 900 | $54.05 | $48,648.51 |
DisclosureSEC source: 0001562180-21-006965 · primarydocument.xml · nonDerivative · entry 1 HRUSOVSKY E KEVIN · CIK 0001252546 · Director · Chairman and CEO 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 901,911 F1 · shares: The sale of shares was effected pursuant to a 10b5-1 trading plan adopted on December 14, 2020. F2 · price: This transaction was executed in multiple trades at prices ranging from $53.73 to $54.44. The price reported reflects the weighted average sale price. The reporting person undertakes to provide upon request to the SEC staff, the issuer or any security holder of the issuer full information regarding the number of shares and prices at which the transaction was effected. F3 · balance_after: Includes 65,504 restricted stock units and 39,815 shares of common stock that are subject to performance based vesting. Read SEC document |
| November 05, 2021 Filed Nov 8, 2021 21:26 UTC |
Mattoon DawnSr. VP, Diagnostics
|
Exercise / conversionStock Option (right to buy) · Derivative | 10,718 | $0.00 Strike: $19.12 | $0.00 |
DisclosureSEC source: 0001562180-21-006883 · primarydocument.xml · derivative · entry 5 Mattoon Dawn · CIK 0001731785 · Sr. VP, Diagnostics 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 10,557 Underlying: Common Stock · 10,718 shares Expires 2028-05-10 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F5 · derivative.exercise_date: The option vests as to 25% of the shares on May 10, 2019 and vests as to an additional 2.083% of the shares per month for 36 months thereafter. Read SEC document |
| November 05, 2021 Filed Nov 8, 2021 21:26 UTC |
Mattoon DawnSr. VP, Diagnostics
|
SaleCommon Stock | 200 | $58.39 | $11,678.50 |
DisclosureSEC source: 0001562180-21-006883 · primarydocument.xml · nonDerivative · entry 4 Mattoon Dawn · CIK 0001731785 · Sr. VP, Diagnostics 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 38,697 F1 · kind: The sale of shares was effected pursuant to a Rule 10b5-1 trading plan adopted on March 15, 2021. F4 · price: This transaction was executed in multiple trades at prices ranging from $58.35 to $58.435.The price reported reflects the weighted average sale price. The reporting person undertakes to provide upon request to the SEC staff, the issuer or any security holder of the issuer full information regarding the number of shares and prices at which the transaction was effected. F2 · balance_after: Includes 13,966 restricted stock units. Read SEC document |
| November 05, 2021 Filed Nov 8, 2021 21:26 UTC |
Mattoon DawnSr. VP, Diagnostics
|
SaleCommon Stock | 8,335 | $57.25 | $477,172.92 |
DisclosureSEC source: 0001562180-21-006883 · primarydocument.xml · nonDerivative · entry 3 Mattoon Dawn · CIK 0001731785 · Sr. VP, Diagnostics 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 38,897 F1 · kind: The sale of shares was effected pursuant to a Rule 10b5-1 trading plan adopted on March 15, 2021. F3 · price: This transaction was executed in multiple trades at prices ranging from $57.00 to $57.975. The price reported reflects the weighted average sale price. The reporting person undertakes to provide upon request to the SEC staff, the issuer or any security holder of the issuer full information regarding the number of shares and prices at which the transaction was effected. F2 · balance_after: Includes 13,966 restricted stock units. Read SEC document |
| November 05, 2021 Filed Nov 8, 2021 21:26 UTC |
Mattoon DawnSr. VP, Diagnostics
|
Exercise / conversionCommon Stock | 10,718 | $19.12 | $204,928.16 |
DisclosureSEC source: 0001562180-21-006883 · primarydocument.xml · nonDerivative · entry 2 Mattoon Dawn · CIK 0001731785 · Sr. VP, Diagnostics 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 47,232 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F2 · balance_after: Includes 13,966 restricted stock units. Read SEC document |
| November 04, 2021 Filed Nov 8, 2021 21:26 UTC |
Mattoon DawnSr. VP, Diagnostics
|
SaleCommon Stock | 1 | $57.00 | $57.00 |
DisclosureSEC source: 0001562180-21-006883 · primarydocument.xml · nonDerivative · entry 1 Mattoon Dawn · CIK 0001731785 · Sr. VP, Diagnostics 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 36,514 F1 · kind: The sale of shares was effected pursuant to a Rule 10b5-1 trading plan adopted on March 15, 2021. Read SEC document |
| November 02, 2021 Filed Nov 4, 2021 16:19 UTC |
Fry John JGeneral Counsel & Secretary
|
SaleCommon Stock | 92 | $53.14 | $4,889.33 |
DisclosureSEC source: 0001562180-21-006833 · primarydocument.xml · nonDerivative · entry 2 Fry John J · CIK 0001419544 · General Counsel & Secretary 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 32,678 F1 · shares: The sales of shares reported on this Form 4 were made solely to cover tax obligations upon the vesting of 700 RSUs. F4 · price: This transaction was executed in multiple trades at prices ranging from $52.96 to $53.78.The price reported reflects the weighted average sale price. The reporting person undertakes to provide upon request to the SEC staff, the issuer or any security holder of the issuer full information regarding the number of shares and prices at which the transaction was effected. Read SEC document |
| November 02, 2021 Filed Nov 4, 2021 16:19 UTC |
Fry John JGeneral Counsel & Secretary
|
SaleCommon Stock | 239 | $52.40 | $12,522.98 |
DisclosureSEC source: 0001562180-21-006833 · primarydocument.xml · nonDerivative · entry 1 Fry John J · CIK 0001419544 · General Counsel & Secretary 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 32,770 F1 · shares: The sales of shares reported on this Form 4 were made solely to cover tax obligations upon the vesting of 700 RSUs. F2 · price: This transaction was executed in multiple trades at prices ranging from $51.86 to $52.85. The price reported reflects the weighted average sale price. The reporting person undertakes to provide upon request to the SEC staff, the issuer or any security holder of the issuer full information regarding the number of shares and prices at which the transaction was effected. F3 · balance_after: Includes 18,870 restricted stock units. Read SEC document |
| November 02, 2021 Filed Nov 4, 2021 16:19 UTC |
HRUSOVSKY E KEVINDirector · Chairman and CEO
|
SaleCommon Stock | 979 | $53.14 | $52,028.86 |
DisclosureSEC source: 0001562180-21-006834 · primarydocument.xml · nonDerivative · entry 2 HRUSOVSKY E KEVIN · CIK 0001252546 · Director · Chairman and CEO 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 902,811 F1 · shares: The sales of shares reported on this Form 4 were made solely to cover tax obligations upon the vesting of 7,935 RSUs. F4 · price: This transaction was executed in multiple trades at prices ranging from $52.96 to $53.78.The price reported reflects the weighted average sale price. The reporting person undertakes to provide upon request to the SEC staff, the issuer or any security holder of the issuer full information regarding the number of shares and prices at which the transaction was effected. F3 · balance_after: Includes 65,504 restricted stock units and 39,815 shares of common stock that are subject to performance based vesting. Read SEC document |
| November 02, 2021 Filed Nov 4, 2021 16:19 UTC |
HRUSOVSKY E KEVINDirector · Chairman and CEO
|
SaleCommon Stock | 2,526 | $52.40 | $132,355.83 |
DisclosureSEC source: 0001562180-21-006834 · primarydocument.xml · nonDerivative · entry 1 HRUSOVSKY E KEVIN · CIK 0001252546 · Director · Chairman and CEO 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 903,790 F1 · shares: The sales of shares reported on this Form 4 were made solely to cover tax obligations upon the vesting of 7,935 RSUs. F2 · price: This transaction was executed in multiple trades at prices ranging from $51.86 to $52.85. The price reported reflects the weighted average sale price. The reporting person undertakes to provide upon request to the SEC staff, the issuer or any security holder of the issuer full information regarding the number of shares and prices at which the transaction was effected. F3 · balance_after: Includes 65,504 restricted stock units and 39,815 shares of common stock that are subject to performance based vesting. Read SEC document |
| November 02, 2021 Filed Nov 4, 2021 20:20 UTC |
Roskey Mark T.SVP, Strategic Partnerships
|
SaleCommon Stock | 39 | $53.14 | $2,072.65 |
DisclosureSEC source: 0001562180-21-006836 · primarydocument.xml · nonDerivative · entry 2 Roskey Mark T. · CIK 0001724565 · SVP, Strategic Partnerships 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 23,416 F1 · shares: The sales of shares reported on this Form 4 were made solely to cover tax obligations upon the vesting of 472 RSUs. F4 · price: This transaction was executed in multiple trades at prices ranging from $52.96 to $53.78.The price reported reflects the weighted average sale price. The reporting person undertakes to provide upon request to the SEC staff, the issuer or any security holder of the issuer full information regarding the number of shares and prices at which the transaction was effected. F3 · balance_after: Includes 11,405 restricted stock units. Read SEC document |
| November 02, 2021 Filed Nov 4, 2021 20:20 UTC |
Roskey Mark T.SVP, Strategic Partnerships
|
SaleCommon Stock | 100 | $52.40 | $5,239.74 |
DisclosureSEC source: 0001562180-21-006836 · primarydocument.xml · nonDerivative · entry 1 Roskey Mark T. · CIK 0001724565 · SVP, Strategic Partnerships 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 23,455 F1 · shares: The sales of shares reported on this Form 4 were made solely to cover tax obligations upon the vesting of 472 RSUs. F2 · price: This transaction was executed in multiple trades at prices ranging from $51.86 to $52.85. The price reported reflects the weighted average sale price. The reporting person undertakes to provide upon request to the SEC staff, the issuer or any security holder of the issuer full information regarding the number of shares and prices at which the transaction was effected. F3 · balance_after: Includes 11,405 restricted stock units. Read SEC document |
| November 02, 2021 Filed Nov 4, 2021 20:19 UTC |
Mattoon DawnSr. VP, Diagnostics
|
SaleCommon Stock | 93 | $53.14 | $4,942.48 |
DisclosureSEC source: 0001562180-21-006835 · primarydocument.xml · nonDerivative · entry 2 Mattoon Dawn · CIK 0001731785 · Sr. VP, Diagnostics 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 36,515 F1 · shares: The sales of shares reported on this Form 4 were made solely to cover tax obligations upon the vesting of 750 RSUs. F4 · price: This transaction was executed in multiple trades at prices ranging from $52.96 to $53.78.The price reported reflects the weighted average sale price. The reporting person undertakes to provide upon request to the SEC staff, the issuer or any security holder of the issuer full information regarding the number of shares and prices at which the transaction was effected. Read SEC document |
| November 02, 2021 Filed Nov 4, 2021 20:19 UTC |
Mattoon DawnSr. VP, Diagnostics
|
SaleCommon Stock | 240 | $52.40 | $12,575.38 |
DisclosureSEC source: 0001562180-21-006835 · primarydocument.xml · nonDerivative · entry 1 Mattoon Dawn · CIK 0001731785 · Sr. VP, Diagnostics 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 36,608 F1 · shares: The sales of shares reported on this Form 4 were made solely to cover tax obligations upon the vesting of 750 RSUs. F2 · price: This transaction was executed in multiple trades at prices ranging from $51.86 to $52.85. The price reported reflects the weighted average sale price. The reporting person undertakes to provide upon request to the SEC staff, the issuer or any security holder of the issuer full information regarding the number of shares and prices at which the transaction was effected. F3 · balance_after: Includes 13,966 restricted stock units. Read SEC document |
| October 22, 2021 Filed Oct 22, 2021 17:48 UTC |
HRUSOVSKY E KEVINDirector · Chairman and CEO
|
SaleCommon Stock | 100 | $51.63 | $5,163.00 |
DisclosureSEC source: 0001562180-21-006622 · primarydocument.xml · nonDerivative · entry 3 HRUSOVSKY E KEVIN · CIK 0001252546 · Director · Chairman and CEO 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 906,316 F1 · shares: The sale of shares was effected pursuant to a 10b5-1 trading plan adopted on December 14, 2020. F3 · balance_after: Includes 73,439 restricted stock units and 39,815 shares of common stock that are subject to performance based vesting. Read SEC document |
| October 22, 2021 Filed Oct 22, 2021 17:48 UTC |
HRUSOVSKY E KEVINDirector · Chairman and CEO
|
SaleCommon Stock | 3,000 | $51.00 | $152,997.60 |
DisclosureSEC source: 0001562180-21-006622 · primarydocument.xml · nonDerivative · entry 2 HRUSOVSKY E KEVIN · CIK 0001252546 · Director · Chairman and CEO 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 906,416 F1 · shares: The sale of shares was effected pursuant to a 10b5-1 trading plan adopted on December 14, 2020. F4 · price: This transaction was executed in multiple trades at prices ranging from $50.63 to $51.50. The price reported reflects the weighted average sale price. The reporting person undertakes to provide upon request to the SEC staff, the issuer or any security holder of the issuer full information regarding the number of shares and prices at which the transaction was effected. F3 · balance_after: Includes 73,439 restricted stock units and 39,815 shares of common stock that are subject to performance based vesting. Read SEC document |
| October 22, 2021 Filed Oct 22, 2021 17:48 UTC |
HRUSOVSKY E KEVINDirector · Chairman and CEO
|
SaleCommon Stock | 1,900 | $50.19 | $95,359.29 |
DisclosureSEC source: 0001562180-21-006622 · primarydocument.xml · nonDerivative · entry 1 HRUSOVSKY E KEVIN · CIK 0001252546 · Director · Chairman and CEO 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 909,416 F1 · shares: The sale of shares was effected pursuant to a 10b5-1 trading plan adopted on December 14, 2020. F2 · price: This transaction was executed in multiple trades at prices ranging from $49.56 to $50.54. The price reported reflects the weighted average sale price. The reporting person undertakes to provide upon request to the SEC staff, the issuer or any security holder of the issuer full information regarding the number of shares and prices at which the transaction was effected. F3 · balance_after: Includes 73,439 restricted stock units and 39,815 shares of common stock that are subject to performance based vesting. Read SEC document |
| October 15, 2021 Filed Oct 19, 2021 20:00 UTC |
Duffy David C.SVP R&D and CTO
|
SaleCommon Stock | 1,667 | $51.47 | $85,800.49 |
DisclosureSEC source: 0001562180-21-006543 · primarydocument.xml · nonDerivative · entry 1 Duffy David C. · CIK 0001724566 · SVP R&D and CTO 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 26,616 F1 · shares: The sale of shares reported on this Form 4 was made pursuant to a Rule 10b5-1 trading plan adopted on March 8, 2021. F2 · balance_after: Includes 9,117 restricted stock units. Read SEC document |
| October 01, 2021 Filed Oct 4, 2021 16:02 UTC |
HRUSOVSKY E KEVINDirector · Chairman and CEO
|
SaleCommon Stock | 3,594 | $51.20 | $184,014.96 |
DisclosureSEC source: 0001562180-21-006230 · primarydocument.xml · nonDerivative · entry 3 HRUSOVSKY E KEVIN · CIK 0001252546 · Director · Chairman and CEO 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 911,316 F4 · shares: The sales of shares reported on this Form 4 were made solely to cover tax obligations upon the vesting of 7,935 RSUs. F5 · balance_after: Includes 73,439 restricted stock units and 39,815 shares of common stock that are subject to performance based vesting. Read SEC document |
| October 01, 2021 Filed Oct 5, 2021 20:01 UTC |
MEISTER PAUL MDirector
|
GrantCommon Stock | 269 | $51.18 | $13,767.42 |
DisclosureSEC source: 0001562180-21-006296 · primarydocument.xml · nonDerivative · entry 1 MEISTER PAUL M · CIK 0001033876 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 13,930 F1 · shares: Consists of stock granted in lieu of cash fees for service on the Company's Board of Directors and committees thereof for the third quarter of 2021. F2 · price: Closing price of the Company's common stock on the Nasdaq Global Market on October 1, 2021. F3 · balance_after: Includes 2,270 restricted stock units. Read SEC document |
| October 01, 2021 Filed Oct 5, 2021 16:01 UTC |
Hlavinka Sarah E.Director
|
GrantCommon Stock | 232 | $51.18 | $11,873.76 |
DisclosureSEC source: 0001562180-21-006298 · primarydocument.xml · nonDerivative · entry 1 Hlavinka Sarah E. · CIK 0001433554 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 11,892 F1 · shares: Consists of stock granted in lieu of cash fees for service on the Company's Board of Directors and committees thereof for the third quarter of 2021. F2 · price: Closing price of the Company's common stock on the Nasdaq Global Market on October 1, 2021. F3 · balance_after: Includes 5,297 restricted stock units. Read SEC document |
| October 01, 2021 Filed Oct 5, 2021 16:02 UTC |
Fry John JGeneral Counsel & Secretary
|
SaleCommon Stock | 340 | $51.20 | $17,408.20 |
DisclosureSEC source: 0001562180-21-006301 · primarydocument.xml · nonDerivative · entry 1 Fry John J · CIK 0001419544 · General Counsel & Secretary 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 33,009 F1 · shares: The sales of shares reported on this Form 4 were made solely to cover tax obligations upon the vesting of 700 RSUs. F2 · balance_after: Includes 19,570 restricted stock units. Read SEC document |
| October 01, 2021 Filed Oct 5, 2021 20:01 UTC |
Madaus Martin DDirector
|
GrantCommon Stock | 354 | $51.18 | $18,117.72 |
DisclosureSEC source: 0001562180-21-006297 · primarydocument.xml · nonDerivative · entry 1 Madaus Martin D · CIK 0001310268 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 15,348 F1 · shares: Consists of stock granted in lieu of cash fees for service on the Company's Board of Directors and committees thereof for the third quarter of 2021. F2 · price: Closing price of the Company's common stock on the Nasdaq Global Market on October 1, 2021. F3 · balance_after: Includes 2,270 restricted stock units. Read SEC document |
| October 01, 2021 Filed Oct 5, 2021 20:02 UTC |
CRANDELL KEITHDirector · 10% owner
|
GrantCommon Stock | 254 | $51.18 | $12,999.72 |
DisclosureSEC source: 0001562180-21-006302 · primarydocument.xml · nonDerivative · entry 7 CRANDELL KEITH · CIK 0001219039 · Director · 10% owner 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 96,012 F5 · shares: Consists of stock granted in lieu of cash fees for service on the Company's Board of Directors and committees thereof for the third quarter of 2021. F6 · price: Closing price of the Company's common stock on the Nasdaq Global Market on October 1, 2021. F7 · balance_after: Includes 2,270 restricted stock units. Read SEC document |
| October 01, 2021 Filed Oct 5, 2021 20:02 UTC |
Mattoon DawnSr. VP, Diagnostics
|
SaleCommon Stock | 342 | $51.20 | $17,510.61 |
DisclosureSEC source: 0001562180-21-006300 · primarydocument.xml · nonDerivative · entry 1 Mattoon Dawn · CIK 0001731785 · Sr. VP, Diagnostics 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 36,848 F1 · shares: The sales of shares reported on this Form 4 were made solely to cover tax obligations upon the vesting of 750 RSUs. F2 · balance_after: Includes 14,716 restricted stock units. Read SEC document |
| October 01, 2021 Filed Oct 5, 2021 20:02 UTC |
Roskey Mark T.SVP, Strategic Partnerships
|
SaleCommon Stock | 143 | $51.20 | $7,321.69 |
DisclosureSEC source: 0001562180-21-006299 · primarydocument.xml · nonDerivative · entry 1 Roskey Mark T. · CIK 0001724565 · SVP, Strategic Partnerships 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 23,555 F1 · shares: The sales of shares reported on this Form 4 were made solely to cover tax obligations upon the vesting of 472 RSUs. F2 · balance_after: Includes 11,877 restricted stock units. Read SEC document |
| September 30, 2021 Filed Oct 4, 2021 16:02 UTC |
HRUSOVSKY E KEVINDirector · Chairman and CEO
|
SaleCommon Stock | 4,600 | $49.22 | $226,432.70 |
DisclosureSEC source: 0001562180-21-006230 · primarydocument.xml · nonDerivative · entry 2 HRUSOVSKY E KEVIN · CIK 0001252546 · Director · Chairman and CEO 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 914,910 F1 · shares: The sale of shares was effected pursuant to a 10b5-1 trading plan adopted on December 14, 2020. F3 · price: This transaction was executed in multiple trades at prices ranging from $48.74 to $49.59. The price reported reflects the weighted average sale price. The reporting person undertakes to provide upon request to the SEC staff, the issuer or any security holder of the issuer full information regarding the number of shares and prices at which the transaction was effected. F2 · balance_after: Includes 81,374 restricted stock units and 39,815 shares of common stock that are subject to performance based vesting. Read SEC document |
| September 30, 2021 Filed Oct 4, 2021 16:02 UTC |
HRUSOVSKY E KEVINDirector · Chairman and CEO
|
SaleCommon Stock | 400 | $47.54 | $19,016.00 |
DisclosureSEC source: 0001562180-21-006230 · primarydocument.xml · nonDerivative · entry 1 HRUSOVSKY E KEVIN · CIK 0001252546 · Director · Chairman and CEO 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 919,510 F1 · shares: The sale of shares was effected pursuant to a 10b5-1 trading plan adopted on December 14, 2020. F2 · balance_after: Includes 81,374 restricted stock units and 39,815 shares of common stock that are subject to performance based vesting. Read SEC document |
| September 22, 2021 Filed Oct 4, 2021 20:09 UTC |
Duffy David C.SVP R&D and CTO
|
SaleCommon Stock | 1,667 | $47.72 | $79,549.24 |
DisclosureSEC source: 0001562180-21-006231 · primarydocument.xml · nonDerivative · entry 1 Duffy David C. · CIK 0001724566 · SVP R&D and CTO 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 28,283 F1 · shares: The sale of shares reported on this Form 4 was made pursuant to a Rule 10b5-1 trading plan adopted on March 8, 2021. F2 · balance_after: Includes 9,117 restricted stock units. Read SEC document |
| September 02, 2021 Filed Sep 3, 2021 16:01 UTC |
HRUSOVSKY E KEVINDirector · Chairman, President & CEO
|
SaleCommon Stock | 4 | $50.24 | $200.96 |
DisclosureSEC source: 0001562180-21-005792 · primarydocument.xml · nonDerivative · entry 4 HRUSOVSKY E KEVIN · CIK 0001252546 · Director · Chairman, President & CEO 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 919,910 F5 · shares: The sale of shares was effected pursuant to a 10b5-1 trading plan adopted on December 14, 2020. F3 · balance_after: Includes 81,374 restricted stock units and 39,815 shares of common stock that are subject to performance based vesting. Read SEC document |
| September 02, 2021 Filed Sep 3, 2021 16:01 UTC |
HRUSOVSKY E KEVINDirector · Chairman, President & CEO
|
SaleCommon Stock | 4,996 | $49.66 | $248,105.86 |
DisclosureSEC source: 0001562180-21-005792 · primarydocument.xml · nonDerivative · entry 3 HRUSOVSKY E KEVIN · CIK 0001252546 · Director · Chairman, President & CEO 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 919,914 F5 · shares: The sale of shares was effected pursuant to a 10b5-1 trading plan adopted on December 14, 2020. F6 · price: This transaction was executed in multiple trades at prices ranging from $49.21 to $50.18. The price reported reflects the weighted average sale price. The reporting person undertakes to provide upon request to the SEC staff, the issuer or any security holder of the issuer full information regarding the number of shares and prices at which the transaction was effected. F3 · balance_after: Includes 81,374 restricted stock units and 39,815 shares of common stock that are subject to performance based vesting. Read SEC document |
| September 01, 2021 Filed Sep 3, 2021 16:01 UTC |
Fry John JGeneral Counsel & Secretary
|
SaleCommon Stock | 50 | $50.75 | $2,537.43 |
DisclosureSEC source: 0001562180-21-005794 · primarydocument.xml · nonDerivative · entry 2 Fry John J · CIK 0001419544 · General Counsel & Secretary 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 33,349 F1 · shares: The sales of shares reported on this Form 4 were made solely to cover tax obligations upon the vesting of 700 RSUs. F4 · price: This transaction was executed in multiple trades at prices ranging from $50.39 to $51.21. The price reported reflects the weighted average sale price. The reporting person undertakes to provide upon request to the SEC staff, the issuer or any security holder of the issuer full information regarding the number of shares and prices at which the transaction was effected. F3 · balance_after: Includes 20,270 restricted stock units. Read SEC document |
| September 01, 2021 Filed Sep 3, 2021 16:01 UTC |
Fry John JGeneral Counsel & Secretary
|
SaleCommon Stock | 300 | $49.78 | $14,934.60 |
DisclosureSEC source: 0001562180-21-005794 · primarydocument.xml · nonDerivative · entry 1 Fry John J · CIK 0001419544 · General Counsel & Secretary 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 33,399 F1 · shares: The sales of shares reported on this Form 4 were made solely to cover tax obligations upon the vesting of 700 RSUs. F2 · price: This transaction was executed in multiple trades at prices ranging from $49.32 to $50.22. The price reported reflects the weighted average sale price. The reporting person undertakes to provide upon request to the SEC staff, the issuer or any security holder of the issuer full information regarding the number of shares and prices at which the transaction was effected. F3 · balance_after: Includes 20,270 restricted stock units. Read SEC document |
| September 01, 2021 Filed Sep 3, 2021 16:01 UTC |
HRUSOVSKY E KEVINDirector · Chairman, President & CEO
|
SaleCommon Stock | 534 | $50.75 | $27,099.70 |
DisclosureSEC source: 0001562180-21-005792 · primarydocument.xml · nonDerivative · entry 2 HRUSOVSKY E KEVIN · CIK 0001252546 · Director · Chairman, President & CEO 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 924,910 F1 · shares: The sales of shares reported on this Form 4 were made solely to cover tax obligations upon the vesting of 7,935 RSUs. F4 · price: This transaction was executed in multiple trades at prices ranging from $50.39 to $51.21. The price reported reflects the weighted average sale price. The reporting person undertakes to provide upon request to the SEC staff, the issuer or any security holder of the issuer full information regarding the number of shares and prices at which the transaction was effected. F3 · balance_after: Includes 81,374 restricted stock units and 39,815 shares of common stock that are subject to performance based vesting. Read SEC document |
| September 01, 2021 Filed Sep 3, 2021 16:01 UTC |
HRUSOVSKY E KEVINDirector · Chairman, President & CEO
|
SaleCommon Stock | 3,175 | $49.78 | $158,057.85 |
DisclosureSEC source: 0001562180-21-005792 · primarydocument.xml · nonDerivative · entry 1 HRUSOVSKY E KEVIN · CIK 0001252546 · Director · Chairman, President & CEO 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 925,444 F1 · shares: The sales of shares reported on this Form 4 were made solely to cover tax obligations upon the vesting of 7,935 RSUs. F2 · price: This transaction was executed in multiple trades at prices ranging from $49.32 to $50.22. The price reported reflects the weighted average sale price. The reporting person undertakes to provide upon request to the SEC staff, the issuer or any security holder of the issuer full information regarding the number of shares and prices at which the transaction was effected. F3 · balance_after: Includes 81,374 restricted stock units and 39,815 shares of common stock that are subject to performance based vesting. Read SEC document |
| September 01, 2021 Filed Sep 3, 2021 20:01 UTC |
Roskey Mark T.SVP, Strategic Partnerships
|
SaleCommon Stock | 21 | $50.75 | $1,065.72 |
DisclosureSEC source: 0001562180-21-005795 · primarydocument.xml · nonDerivative · entry 2 Roskey Mark T. · CIK 0001724565 · SVP, Strategic Partnerships 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 23,698 F1 · shares: The sales of shares reported on this Form 4 were made solely to cover tax obligations upon the vesting of 472 RSUs. F4 · price: This transaction was executed in multiple trades at prices ranging from $50.39 to $51.21. The price reported reflects the weighted average sale price. The reporting person undertakes to provide upon request to the SEC staff, the issuer or any security holder of the issuer full information regarding the number of shares and prices at which the transaction was effected. F3 · balance_after: Includes 12,349 restricted stock units. Read SEC document |
| September 01, 2021 Filed Sep 3, 2021 20:01 UTC |
Roskey Mark T.SVP, Strategic Partnerships
|
SaleCommon Stock | 126 | $49.78 | $6,272.53 |
DisclosureSEC source: 0001562180-21-005795 · primarydocument.xml · nonDerivative · entry 1 Roskey Mark T. · CIK 0001724565 · SVP, Strategic Partnerships 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 23,719 F1 · shares: The sales of shares reported on this Form 4 were made solely to cover tax obligations upon the vesting of 472 RSUs. F2 · price: This transaction was executed in multiple trades at prices ranging from $49.32 to $50.22. The price reported reflects the weighted average sale price. The reporting person undertakes to provide upon request to the SEC staff, the issuer or any security holder of the issuer full information regarding the number of shares and prices at which the transaction was effected. F3 · balance_after: Includes 12,349 restricted stock units. Read SEC document |
| September 01, 2021 Filed Sep 3, 2021 20:01 UTC |
Mattoon DawnSr. VP, Diagnostics
|
SaleCommon Stock | 51 | $50.75 | $2,588.17 |
DisclosureSEC source: 0001562180-21-005793 · primarydocument.xml · nonDerivative · entry 2 Mattoon Dawn · CIK 0001731785 · Sr. VP, Diagnostics 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 37,190 F1 · shares: The sales of shares reported on this Form 4 were made solely to cover tax obligations upon the vesting of 750 RSUs. F4 · price: This transaction was executed in multiple trades at prices ranging from $50.39 to $51.21. The price reported reflects the weighted average sale price. The reporting person undertakes to provide upon request to the SEC staff, the issuer or any security holder of the issuer full information regarding the number of shares and prices at which the transaction was effected. F3 · balance_after: Includes 15,466 restricted stock units. Read SEC document |
| September 01, 2021 Filed Sep 3, 2021 20:01 UTC |
Mattoon DawnSr. VP, Diagnostics
|
SaleCommon Stock | 302 | $49.78 | $15,034.16 |
DisclosureSEC source: 0001562180-21-005793 · primarydocument.xml · nonDerivative · entry 1 Mattoon Dawn · CIK 0001731785 · Sr. VP, Diagnostics 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 37,241 F1 · shares: The sales of shares reported on this Form 4 were made solely to cover tax obligations upon the vesting of 750 RSUs. F2 · price: This transaction was executed in multiple trades at prices ranging from $49.32 to $50.22. The price reported reflects the weighted average sale price. The reporting person undertakes to provide upon request to the SEC staff, the issuer or any security holder of the issuer full information regarding the number of shares and prices at which the transaction was effected. F3 · balance_after: Includes 15,466 restricted stock units. Read SEC document |
| August 20, 2021 Filed Aug 20, 2021 20:08 UTC |
Duffy David C.SVP R&D and CTO
|
SaleCommon Stock | 1,667 | $46.13 | $76,898.71 |
DisclosureSEC source: 0001562180-21-005490 · primarydocument.xml · nonDerivative · entry 1 Duffy David C. · CIK 0001724566 · SVP R&D and CTO 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 29,950 F1 · shares: The sale of shares reported on this Form 4 was made pursuant to a Rule 10b5-1 trading plan adopted on March 8, 2021. F2 · balance_after: Includes 9,483 restricted stock units. Read SEC document |
| August 17, 2021 Filed Oct 5, 2021 20:02 UTC |
CRANDELL KEITHDirector · 10% owner
|
OtherCommon Stock | 9,954 | $0.00 | $0.00 |
DisclosureSEC source: 0001562180-21-006302 · primarydocument.xml · nonDerivative · entry 6 CRANDELL KEITH · CIK 0001219039 · Director · 10% owner 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 95,758 F1 · kind: Distribution of Common Stock held by a limited partnership to its partners for no consideration. F4 · kind: Change from indirect to direct ownership of shares previously reported as beneficially owned by the Reporting Person. Read SEC document |
| August 17, 2021 Filed Oct 5, 2021 20:02 UTC |
CRANDELL KEITHDirector · 10% owner
|
OtherCommon Stock | 120,689 | $0.00 | $0.00 |
DisclosureSEC source: 0001562180-21-006302 · primarydocument.xml · nonDerivative · entry 5 CRANDELL KEITH · CIK 0001219039 · Director · 10% owner 10b5-1 filing: Not disclosed Ownership: Indirect · See Footnote Disclosed balance after: 233,692 F1 · kind: Distribution of Common Stock held by a limited partnership to its partners for no consideration. F3 · ownership.nature: These shares are directly held by ARCH Venture Fund VIII Overage, L.P. ("ARCH Overage"). ARCH Venture Partners VIII, LLC ("ARCH VIII LLC") the sole general partner of ARCH Overage, may be deemed to beneficially own the shares held by ARCH Overage. The Reporting Person is a managing director of the ARCH VIII LLC and shares voting and investment control with respect to these shares. The Reporting Person may be deemed to beneficially own the shares held by ARCH Overage. The Reporting Person disclaims beneficial ownership of the securities reported herein, except to the extent of his pecuniary interest therein, if any. Read SEC document |
| August 17, 2021 Filed Oct 5, 2021 20:02 UTC |
CRANDELL KEITHDirector · 10% owner
|
OtherCommon Stock | 189,311 | $0.00 | $0.00 |
DisclosureSEC source: 0001562180-21-006302 · primarydocument.xml · nonDerivative · entry 4 CRANDELL KEITH · CIK 0001219039 · Director · 10% owner 10b5-1 filing: Not disclosed Ownership: Indirect · See Footnote Disclosed balance after: 366,558 F1 · kind: Distribution of Common Stock held by a limited partnership to its partners for no consideration. F2 · ownership.nature: These shares are directly held by ARCH Venture Fund VI, L.P. ("ARCH VI"). ARCH Venture Partners VI, L.P. ("GPLP"), the sole general partner of ARCH VI, may be deemed to beneficially own the shares held by ARCH VI. ARCH Venture Partners VI, LLC ("GPLLC"), as the sole general partner of GPLP, may be deemed to beneficially own the shares held by ARCH VI. The Reporting Person is a managing director of the GPLLC and shares voting and investment control with respect to these shares. The Reporting Person may be deemed to beneficially own the shares held by ARCH VI. The Reporting Person disclaims beneficial ownership of the securities reported herein, except to the extent of his pecuniary interest therein, if any. Read SEC document |
Value uses the disclosed total when available, otherwise shares × reported transaction price. It is not an estimate of exercise cash cost or investment performance.